Evaluation of the C6 Lyme Enzyme Immunoassay for the Diagnosis of Lyme Disease in Children and Adolescents | Zendy

Susan C. Lipsett | Zendy; John A. Branda | Zendy; Alexander J. McAdam | Zendy; Louis Vernacchio | Zendy; Caroline D. Gordon | Zendy; Catherine R. Gordon | Zendy; Lise E. Nigrovic | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Evaluation of the C6 Lyme Enzyme Immunoassay for the Diagnosis of Lyme Disease in Children and Adolescents

Author(s) -

Susan C. Lipsett,

John A. Branda,

Alexander J. McAdam,

Louis Vernacchio,

Caroline D. Gordon,

Catherine R. Gordon,

Lise E. Nigrovic

Publication year - 2016

Publication title -

clinical infectious diseases

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 3.44

H-Index - 336

eISSN - 1537-6591

pISSN - 1058-4838

DOI - 10.1093/cid/ciw427

Subject(s) - lyme disease , medicine , lyme , serology , erythema migrans , immunoassay , immunology , borrelia burgdorferi , antibody , lyme borreliosis

The commercially-available C6 Lyme enzyme immunoassay (EIA) has been approved to replace the standard whole-cell sonicate EIA as a first-tier test for the diagnosis of Lyme disease and has been suggested as a stand-alone diagnostic. However, the C6 EIA has not been extensively studied in pediatric patients undergoing evaluation for Lyme disease.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research